V. Ramakrishnan

发表

Inhibitors of the Cyclin-Dependent Kinase and PIM Kinase Pathways in the Treatment of Myeloma

Shaji K. Kumar, V. Ramakrishnan, 2016, Cancer journal.

Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs

Shaji K. Kumar, S. Rajkumar, A. Adjei, 2010, Oncogene.

TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells

S. Vincent Rajkumar, Shaji K. Kumar, A. Tefferi, 2010, American journal of hematology.

Latent hypoparathyroidism in children with conotruncal cardiac defects.

B. Cuneo, D. Driscoll, V. Ramakrishnan, 1996, Circulation.

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2019, Haematologica.

Photoaging and Anti‐Photoaging Activity of Compounds Derived From Marine Origin

V. Ramakrishnan, Shiek S. S. J. Ahmed, R. Husain, 2020 .

Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001.

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2014, Leukemia research.

MECP2 Mutations Associated with Rett Syndrome - Molecular Approaches

V. Ramakrishnan, 2016 .

Inhibitor of Apoptosis Proteins (IAPs) as therapeutic targets in Multiple Myeloma (MM)

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2014, Leukemia.

Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2016, Oncotarget.

Natriuretic Peptides, Inflammation, and Sounding the Alarm.

V. Ramakrishnan, J. Burnett, 2020, Circulation. Heart failure.

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2018, Oncotarget.

MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma

S. Ansell, V. Ramakrishnan, M. Timm, 2012, Leukemia.

MULTIPLE MYELOMA ( P KAPOOR , SECTION EDITOR ) Signaling Pathways and Emerging Therapies in Multiple Myeloma

V. Ramakrishnan, A. D’Souza, D. Anita, 2016 .

Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2012, PloS one.

PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise

Shaji K. Kumar, V. Ramakrishnan, 2018, Leukemia & lymphoma.

Sorafenib, a multikinase inhibitor, is effective in vitro against non‐hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin

S. Vincent Rajkumar, Shaji K. Kumar, A. Adjei, 2012, American journal of hematology.

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma

Shaji K. Kumar, V. Ramakrishnan, N. Tandon, 2016, Clinical pharmacology : advances and applications.

Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.

K. Nair, Shaji K. Kumar, V. Ramakrishnan, 2018, JCI insight.

Bortezomib combination therapy in multiple myeloma.

S. Rajkumar, V. Ramakrishnan, P. Kapoor, 2012, Seminars in hematology.

Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host

V. Ramakrishnan, R. Murugesan, Shiek S. S. J. Ahmed, 2020, Frontiers in Physiology.

Systems Biological Approach of Molecular Descriptors Connectivity: Optimal Descriptors for Oral Bioavailability Prediction

V. Ramakrishnan, Shiek S. S. J. Ahmed, V. Ramakrishnan, 2012, PloS one.

Neuroprotective Compounds from Marine Microorganisms

V. Ramakrishnan, Shiek S. S. J. Ahmed, R. Husain, 2020 .

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma

H. Kumar, Shaji K. Kumar, S. Rajkumar, 2020, Blood Cancer Journal.

Association between MDR1 gene polymorphisms and Parkinson's disease in Asian and Caucasian populations: a meta-analysis

V. Ramakrishnan, Shiek S. S. J. Ahmed, Suresh Kumar, 2016, Journal of the Neurological Sciences.

Mechanism of Action of a Novel c-Met Inhibitor MK2461 In Multiple Myeloma

Shaji K. Kumar, S. Rajkumar, V. Ramakrishnan, 2010 .

Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis

V. Ramakrishnan, Shiek S. S. J. Ahmed, Suresh Kumar, 2017, NeuroMolecular Medicine.

Economic Messages in Prescription Drug Advertisements in Medical Journals

C. Bell, V. Ramakrishnan, P. Neumann, 2002, Medical care.

Klinefelter syndrome and its association with male infertility

V. Ramakrishnan, S. Kumar, R. Pandiyan, 2014 .

Sorafenib, a multikinase inhibitor, is effective in vitro against non‐hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin

S. Vincent Rajkumar, Shaji K. Kumar, A. Adjei, 2012, American journal of hematology.

Association Between NOS1 Gene Polymorphisms and Schizophrenia in Asian and Caucasian Populations: A Meta-Analysis

V. Ramakrishnan, Shiek S. S. J. Ahmed, Suresh Kumar, 2017, NeuroMolecular Medicine.

Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.

V. Ramakrishnan, T. Hitosugi, Xuan-Mai Petterson, 2018, JCI insight.